Strengthening capacity-building in malaria and schistosomiasis control under China-Africa cooperation: Assessing a case study of Burkina Faso

Li, Hongmei; Djibougou, Diakourga Arthur; Lu, Shuliang; Lv, Shan; Zongo, Dramane; Wang, Duoquan; Ding, Wei; Qian, Yingjun; Huang, Lan; Guan, Yalin; Xiao, Ning; Diagbouga, Potiandi Serge; Engels, Dirk; Zhou, Xiao-Nong

doi:10.1016/j.soh.2023.100009

Cited by 3 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[ 7 ] focus on the distribution of dog bits in Pakistan to call for rabies prevention. Li [ 9 ] et al. summarize the advances of China–Africa cooperation in malaria and schistosomiasis control and prevention in Burkina Faso.…”

Section: Power Of One Healthmentioning

confidence: 99%

Power of One Health: the first year of Science in One Health

Zhao,

Wu,

et al. 2023

Science in One Health

Self Cite

View full text Add to dashboard Cite

Section: Power Of One Healthmentioning

confidence: 99%

Power of One Health: the first year of Science in One Health

Zhao,

Wu,

et al. 2023

Science in One Health

Self Cite

View full text Add to dashboard Cite

New clinical application prospects of artemisinin and its derivatives: a scoping review

Huang,

Yang,

Liu

et al. 2023

Infect Dis Poverty

View full text Add to dashboard Cite

Background Recent research has suggested that artemisinin and its derivatives may have therapeutic effects on parasites, viruses, tumors, inflammation and skin diseases. This study aimed to review clinical research on artemisinin and its derivatives except anti-malaria and explore possible priority areas for future development. Methods Relevant articles in English and Chinese published before 28 October 2021 were reviewed. All articles were retrieved and obtained from databases including WanFang, PubMed/MEDLINE, the Cochrane Library, China National Knowledge International, Embase, OpenGrey, the Grey Literature Report, Grey Horizon, and ClinicalTrials.gov. Studies were selected for final inclusion based on predefined criteria. Information was then extracted and analyzed by region, disease, outcome, and time to identify relevant knowledge gaps. Results Seventy-seven studies on anti-parasitic (35), anti-tumor (16), anti-inflammatory (12), anti-viral (8), and dermatological treatments (7) focused on the safety and efficacy of artemisinin and its derivatives. The anti-parasitic clinical research developed rapidly, with a large number of trials, rapid clinical progress, and multiple research topics. In contrast, anti-viral research was limited and mainly stayed in phase I clinical trials (37.50%). Most of the studies were conducted in Asia (60%), followed by Africa (27%), Europe (8%), and the Americas (5%). Anti-parasite and anti-inflammatory research were mainly distributed in less developed continents such as Asia and Africa, while cutting-edge research such as anti-tumor has attracted more attention in Europe and the United States. At the safety level, 58 articles mentioned the adverse reactions of artemisinin and its derivatives, with only one study showing a Grade 3 adverse event, while the other studies did not show any related adverse reactions or required discontinuation. Most studies have discovered therapeutic effects of artemisinin or its derivatives on anti-parasitic (27), anti-tumor (9), anti-inflammatory (9) and dermatological treatment (6). However, the efficacy of artemisinin-based combination therapies (ACTs) for parasitic diseases (non-malaria) is still controversial. Conclusions Recent clinical studies suggest that artemisinin and its derivatives may be safe and effective candidates for anti-tumor, anti-parasitic, anti-inflammatory and dermatological drugs. More phase II/III clinical trials of artemisinin and its derivatives on antiviral effects are needed. Graphical Abstract

show abstract

Gut microbiota in parasite-transmitting gastropods

Li,

Hong,

Yuan

et al. 2023

Infect Dis Poverty

View full text Add to dashboard Cite

Background Gastropoda, the largest class within the phylum Mollusca, houses diverse gut microbiota, and some gastropods serve as intermediate hosts for parasites. Studies have revealed that gut bacteria in gastropods are associated with various biological aspects, such as growth, immunity and host–parasite interactions. Here, we summarize our current knowledge of gastropod gut microbiomes and highlight future research priorities and perspectives. Methods A literature search was undertaken using PubMed, Web of Science and CNKI for the articles on the gut microbiota of gastropods until December 31, 2022. We retrieved a total of 166 articles and identified 73 eligible articles for inclusion in this review based on the inclusion and exclusion criteria. Results Our analysis encompassed freshwater, seawater and land snails, with a specific focus on parasite-transmitting gastropods. We found that most studies on gastropod gut microbiota have primarily utilized 16S rRNA gene sequencing to analyze microbial composition, rather than employing metagenomic, metatranscriptomic, or metabolomic approaches. This comprehensive review provided an overview of the parasites carried by snail species in the context of gut microbiota studies. We presented the gut microbial trends, a comprehensive summary of the diversity and composition, influencing factors, and potential functions of gastropod gut microbiota. Additionally, we discussed the potential applications, research gaps and future perspectives of gut microbiomes in parasite-transmitting gastropods. Furthermore, several strategies for enhancing our comprehension of gut microbiomes in snails were also discussed. Conclusions This review comprehensively summarizes the current knowledge on the composition, potential function, influencing factors, potential applications, limitations, and challenges of gut microbiomes in gastropods, with a specific emphasis on parasite-transmitting gastropods. These findings provide important insights for future studies aiming to understand the potential role of gastropod gut microbiota in controlling snail populations and snail-borne diseases. Graphical abstract

show abstract

Strengthening capacity-building in malaria and schistosomiasis control under China-Africa cooperation: Assessing a case study of Burkina Faso

Cited by 3 publications

References 21 publications

Power of One Health: the first year of Science in One Health

Power of One Health: the first year of Science in One Health

New clinical application prospects of artemisinin and its derivatives: a scoping review

Gut microbiota in parasite-transmitting gastropods

Contact Info

Product

Resources

About